Next Article in Journal
FLII and MLL1 Cooperatively Regulate Aryl Hydrocarbon Receptor-Mediated Transcription in ARPE-19 Cells
Next Article in Special Issue
Geraniol Averts Methotrexate-Induced Acute Kidney Injury via Keap1/Nrf2/HO-1 and MAPK/NF-κB Pathways
Previous Article in Journal
Assessment of Bioavailability after In Vitro Digestion and First Pass Metabolism of Bioactive Peptides from Collagen Hydrolysates
Previous Article in Special Issue
Effect of Ducrosia flabellifolia and Savignya parviflora Extracts on Inhibition of Human Colon and Prostate Cancer Cell Lines
Article

Impact of Vitamin D Supplementation on Inflammatory Markers’ Levels in Obese Patients

1
Department of Pharmacology and Therapeutics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Curie 9, 85-090 Bydgoszcz, Poland
2
Department of Urology, Raphaelsklinik, 48143 Münster, Germany
3
Department of Obstetrics and Gynecology, St. Franziskus-Hospital, 48145 Münster, Germany
*
Author to whom correspondence should be addressed.
Academic Editors: Raffaele Capasso and Maria Grazia Ferraro
Curr. Issues Mol. Biol. 2021, 43(3), 1606-1622; https://doi.org/10.3390/cimb43030114
Received: 16 September 2021 / Revised: 11 October 2021 / Accepted: 12 October 2021 / Published: 14 October 2021
In view of research suggesting a possible beneficial impact of vitamin D on systemic inflammatory response, the authors decided to investigate an influence of vitamin D supplementation on serum levels of certain inflammatory markers in obese patients. The current study included such biomarkers as interleukin-6 (IL-6), pituitary adenylate cyclase-activating peptide (PACAP), advanced oxidation protein products (AOPP), C-X3-C Motif Chemokine Ligand 1 (CX3CL1), monocyte chemoattractant protein-1 (MCP-1), and nitric oxide (NO). The measurements were performed with the ELISA method before and after 3-month-long supplementation of 2000 IU of vitamin D orally. The results showed that the therapy did not induce any statistically significant changes in serum levels of MCP-1, IL-6, CX3CL1, and PACAP. The supplementation was related to a significant increase in measurements of NO and AOPP levels, although the correlation analysis between vitamin D concentration after its supplementation and the concentration of the molecular parameters did not show significant relation. In conclusion, our study seems to contradict certain aspects of findings available in the literature regarding the vitamin D’s impact. View Full-Text
Keywords: vitamin D; inflammation; obesity; pathways; pharmacology vitamin D; inflammation; obesity; pathways; pharmacology
Show Figures

Figure 1

MDPI and ACS Style

Wiciński, M.; Ozorowski, M.; Wódkiewicz, E.; Otto, S.W.; Kubiak, K.; Malinowski, B. Impact of Vitamin D Supplementation on Inflammatory Markers’ Levels in Obese Patients. Curr. Issues Mol. Biol. 2021, 43, 1606-1622. https://doi.org/10.3390/cimb43030114

AMA Style

Wiciński M, Ozorowski M, Wódkiewicz E, Otto SW, Kubiak K, Malinowski B. Impact of Vitamin D Supplementation on Inflammatory Markers’ Levels in Obese Patients. Current Issues in Molecular Biology. 2021; 43(3):1606-1622. https://doi.org/10.3390/cimb43030114

Chicago/Turabian Style

Wiciński, Michał, Mateusz Ozorowski, Eryk Wódkiewicz, Stephan W. Otto, Karol Kubiak, and Bartosz Malinowski. 2021. "Impact of Vitamin D Supplementation on Inflammatory Markers’ Levels in Obese Patients" Current Issues in Molecular Biology 43, no. 3: 1606-1622. https://doi.org/10.3390/cimb43030114

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop